Drug Type Small molecule drug |
Synonyms Nasaflex |
Target |
Action agonists, antagonists |
Mechanism GR agonists(Glucocorticoid receptor agonists), H1 receptor antagonists(Histamine H1 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (16 Nov 2012), |
Regulation- |
Molecular FormulaC22H28Cl2O4 |
InChIKeyQLIIKPVHVRXHRI-CXSFZGCWSA-N |
CAS Registry105102-22-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Rhinitis, Allergic, Perennial | South Korea | 16 Nov 2012 |